المؤلفون: Salmanton‑García, Jon, Marchesi, Francesco, Gomes da Silva, Maria, Davila Valls, Julio, Bilgin, Yavuz M., Jimenez Balarezo, Moraima, Farina, Francesca

المساهمون: Institut Català de la Salut, Salmanton-García J University of Cologne, Faculty of Medicine, and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany. University of Cologne, Faculty of Medicine, and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany. German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. Marchesi F Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Gomes da Silva M Portuguese Institute of Oncology, Lisbon, Portugal. Farina F IRCCS Ospedale San Raffaele, Milan, Italy. Dávila-Valls J Hospital Nuestra Señora de Sonsoles, Ávila, Spain. Bilgin YM Department of Internal Medicine, ADRZ, Goes, the Netherlands. Jiménez M Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Sang - Càncer, Medicaments antivírics - Ús terapèutic, COVID-19 (Malaltia) - Tractament, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents, Other subheadings::Other subheadings::/therapeutic use, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antivíricos, Otros calificadores::Otros calificadores::/uso terapéutico, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas

وصف الملف: application/pdf

العلاقة: eClinicalMedicine;58; https://doi.org/10.1016/j.eclinm.2023.101939Test; Salmanton-García J, Marchesi F, Gomes da Silva M, Farina F, Dávila-Valls J, Bilgin YM, et al. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. eClinicalMedicine. 2023 Apr;58:101939.; https://hdl.handle.net/11351/9434Test

الإتاحة: https://doi.org/10.1016/j.eclinm.2023.101939Test
https://hdl.handle.net/11351/9434Test

المؤلفون: Solano de la Asunción, Carlos, Giménez, Estela, Hernandez-Boluda, Juan Carlos, Terol, M. Jose, Albert, Eliseo, López-Jiménez, Javier, Fox, Maria Laura

المساهمون: Institut Català de la Salut, Solano de la Asunción C, Albert E Microbiology Service, INCLIVA Research Institute, Hospital Clínico Universitario, Valencia, Spain. Giménez E Microbiology Service, INCLIVA Research Institute, Hospital Clínico Universitario, Valencia, Spain. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. Hernández-Boluda JC Hematology Service, INCLIVA Research Institute, Hospital Clínico Universitario, Valencia, Spain. Terol MJ Hematology Service, INCLIVA Research Institute, Hospital Clínico Universitario, Valencia, Spain. Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain. López J Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain. Fox ML Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Infeccions per citomegalovirus, Sang - Càncer, ADN, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, DISEASES::Virus Diseases::DNA Virus Infections::Herpesviridae Infections::Cytomegalovirus Infections, CHEMICALS AND DRUGS::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::DNA::DNA, Viral, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas, ENFERMEDADES::virosis::infecciones por virus ADN::infecciones por Herpesviridae::infecciones por Citomegalovirus, COMPUESTOS QUÍMICOS Y DROGAS::nucleótidos y nucleósidos de ácidos nucleicos::ácidos nucleicos::ADN::ADN vírico

وصف الملف: application/pdf

العلاقة: Journal of Medical Virology;95(7); https://doi.org/10.1002/jmv.28933Test; Solano de la Asunción C, Giménez E, Hernández-Boluda JC, Terol MJ, Albert E, López J, et al. Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study. J Med Virol. 2023 Jul;95(7):e28933.; https://hdl.handle.net/11351/10035Test

الإتاحة: https://doi.org/10.1002/jmv.28933Test
https://hdl.handle.net/11351/10035Test

المؤلفون: Cattaneo, Chiara, El-Ashwah, Shaimaa, Itri, Federico, Weinbergerova, Barbora, Jiménez, Moraima, Salmanton-García, Jon, Marchesi, Francesco, Cabirta, Alba

المساهمون: Institut Català de la Salut, Cattaneo C Hematology Unit, ASST-Spedali Civili, Brescia, Italy. Salmanton-García J University of Cologne, Faculty of Medicine, University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany. University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany. Marchesi F Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. El-Ashwah S Oncology Center, Mansoura University, Mansoura, Egypt. Itri F San Luigi Gonzaga Hospital, Orbassano, Italy. Weinbergerová B Masaryk University and University Hospital Brno—Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic. Cabirta A Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Jiménez M Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: COVID-19 (Malaltia) - Diagnòstic, Sang - Càncer - Diagnòstic, Sang - Càncer - Tractament, Avaluació de resultats (Assistència sanitària), DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento

وصف الملف: application/pdf

العلاقة: Cancers;14(22); https://doi.org/10.3390/cancers14225530Test; Cattaneo C, Salmanton-García J, Marchesi F, El-Ashwah S, Itri F, Weinbergerová B, et al. Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey. Cancers. 2022 Nov 10;14(22):5530.; https://hdl.handle.net/11351/9664Test; 000887127200001

الإتاحة: https://doi.org/10.3390/cancers14225530Test
https://hdl.handle.net/11351/9664Test

المؤلفون: Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Federico Itri, Barbora Weinbergerová, Maria Gomes Da Silva, Michelina Dargenio, Julio Dávila-Valls, Sonia Martín-Pérez, Francesca Farina, Jaap Van Doesum, Toni Valković, Caroline Besson, Christian Bjørn Poulsen, Alberto López-García, Pavel Žák, Martin Schönlein, Klára Piukovics, Ozren Jaksic, Alba Cabirta, Natasha Ali, Uluhan Sili, Nicola Fracchiolla, Giulia Dragonetti, Tatjana Adžić-Vukičević, Monia Marchetti, Marina Machado, Andreas Glenthøj, Olimpia Finizio, Fatih Demirkan, Ola Blennow, Maria Chiara Tisi, Ali S. Omrani, Milan Navrátil, Zdeněk Ráčil, Jan Novák, Gabriele Magliano, Moraima Jiménez, Carolina Garcia-Vidal, Nurettin Erben, Maria Ilaria Del Principe, Caterina Buquicchio, Rui Bergantim, Josip Batinić, Murtadha Al-Khabori, Luisa Verga, Tomáš Szotkowski, Michail Samarkos, Irati Ormazabal-Vélez, Stef Meers, Johan Maertens, László Imre Pinczés, Martin Hoenigl, Ľuboš Drgoňa, Annarosa Cuccaro, Yavuz M. Bilgin, Avinash Aujayeb, Laman Rahimli, Stefanie Gräfe, Mariarita Sciumè, Miloš Mladenović, Gökçe Melis Çolak, Maria Vittoria Sacchi, Anna Nordlander, Caroline Berg Venemyr, Michaela Hanáková, Nicole García-Poutón, Ziad Emarah, Giovanni Paolo Maria Zambrotta, Raquel Nunes Rodrigues, Raul Cordoba, Gustavo-Adolfo Méndez, Monika M. Biernat, Oliver A. Cornely, Livio Pagano

المساهمون: Institut Català de la Salut, [Cattaneo C] Hematology Unit, ASST-Spedali Civili, Brescia, Italy. [Salmanton-García J] University of Cologne, Faculty of Medicine, University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany. University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany. [Marchesi F] Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. [El-Ashwah S] Oncology Center, Mansoura University, Mansoura, Egypt. [Itri F] San Luigi Gonzaga Hospital, Orbassano, Italy. [Weinbergerová B] Masaryk University and University Hospital Brno—Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic. [Cabirta A] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Jiménez M] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Cattaneo C., Salmanton-García J., Marchesi F., El-Ashwah S., Itri F., Weinbergerová B., Gomes Da Silva M., Dargenio M., Dávila-Valls J., Martín-Pérez S., et al., Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, EPICOVIDEHA has received funds from Optics COMMITTM (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States (Project 2020-8223)., HAL UVSQ, Équipe

المصدر: Cattaneo, C, Salmanton-García, J, Marchesi, F, El-Ashwah, S, Itri, F, Weinbergerová, B, Gomes Da Silva, M, Dargenio, M, Dávila-Valls, J, Martín-Pérez, S, Farina, F, Van Doesum, J, Valković, T, Besson, C, Poulsen, C B, López-García, A, Žák, P, Schönlein, M, Piukovics, K, Jaksic, O, Cabirta, A, Ali, N, Sili, U, Fracchiolla, N, Dragonetti, G, Adžić-Vukičević, T, Marchetti, M, Machado, M, Glenthøj, A, Finizio, O, Demirkan, F, Blennow, O, Tisi, M C, Omrani, A S, Navrátil, M, Ráčil, Z, Novák, J, Magliano, G, Jiménez, M, Garcia-Vidal, C, Erben, N, Del Principe, M I, Buquicchio, C, Bergantim, R, Batinić, J, Al-Khabori, M, Verga, L, Szotkowski, T, Samarkos, M, Ormazabal-Vélez, I, Meers, S, Maertens, J, Pinczés, L I, Hoenigl, M, Drgoňa, Ľ, Cuccaro, A, Bilgin, Y M, Aujayeb, A, Rahimli, L, Gräfe, S, Sciumè, M, Mladenović, M, Çolak, G M, Sacchi, M V, Nordlander, A, Berg Venemyr, C, Hanáková, M, García-Poutón, N, Emarah, Z, Zambrotta, G P M, Nunes Rodrigues, R, Cordoba, R, Méndez, G A, Biernat, M M, Cornely, O A & Pagano, L 2022, ' Simultaneous Onset of Haematological Malignancy and COVID : An Epicovideha Survey ', Cancers, vol. 14, no. 22, 5530 . https://doi.org/10.3390/cancers14225530Test
Cancers; Volume 14; Issue 22; Pages: 5530
Cancers, 14(22):5530. MDPI AG
Scientia
Cancers
Cancers, 2022, 14 (22), pp.5530. ⟨10.3390/cancers14225530⟩

مصطلحات موضوعية: Internal Diseases, Cancer Research, Sağlık Bilimleri, Other subheadings::Other subheadings::/drug therapy [Other subheadings], İç Hastalıkları, Clinical Medicine (MED), RECOMMENDATIONS, Sang - Càncer - Tractament, BİYOKİMYA VE MOLEKÜLER BİYOLOJİ, INFECTION, virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], haematological malignancy onset, Klinik Tıp (MED), 03.02. Klinikai orvostan, Klinik Tıp, treatment, Temel Bilimler, COVID-19, outcome, prognostic factors, Life Sciences, Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], Onkoloji, Tıp, MOLECULAR BIOLOGY & GENETICS, Oncology, Medicine, ONKOLOJİ, Natural Sciences, BIOCHEMISTRY & MOLECULAR BIOLOGY, Life Sciences & Biomedicine, Sitogenetik, Life Sciences (LIFE), Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], [SDV.CAN]Life Sciences [q-bio]/Cancer, Molecular Biology and Genetics, PANEL, [SDV.CAN] Life Sciences [q-bio]/Cancer, Yaşam Bilimleri, Health Sciences, Cytogenetic, neoplasias::neoplasias por localización::neoplasias hematológicas [ENFERMEDADES], Moleküler Biyoloji ve Genetik, ACUTE LYMPHOBLASTIC-LEUKEMIA, Internal Medicine Sciences, Science & Technology, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Dahili Tıp Bilimleri, CLINICAL MEDICINE, Neoplasms::Neoplasms by Site::Hematologic Neoplasms [DISEASES], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Settore MED/15, Settore MED/15 - MALATTIE DEL SANGUE, Sang - Càncer - Diagnòstic, Yaşam Bilimleri (LIFE), Avaluació de resultats (Assistència sanitària), COVID-19 (Malaltia) - Diagnòstic, Kanser Araştırmaları

وصف الملف: application/pdf; text; Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b32497d572db5dac36ba6a3538eaa29cTest
https://doi.org/10.3390/cancers14225530Test

المؤلفون: Sánchez-Ramón, Silvia, Bermúdez, Arancha, González-Granado, Luis Ignacio, Rodríguez-Gallego, Carlos, Sastre, Ana, Soler Palacín, Pere

المساهمون: Institut Català de la Salut, Sánchez-Ramón S Hospital Clínico San Carlos, Madrid, Spain. Bermúdez A Hospital Universitario Marqués de Valdecilla, Santander, Spain. González-Granado LI Hospital Universitario 12 Octubre, Madrid, Spain. Rodríguez-Gallego C Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Canary Islands, Spain. Sastre A Hospital Universitario La Paz, Madrid, Spain. Soler-Palacín P Hospital Universitari Vall d'Hebron, Barcelona, Spain., Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Síndromes de deficiència immunitària - Diagnòstic, Sang - Càncer, Comorbiditat, DISEASES::Immune System Diseases::Immunologic Deficiency Syndromes, Other subheadings::Other subheadings::/diagnosis, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, HEALTH CARE::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Comorbidity, ENFERMEDADES::enfermedades del sistema inmune::síndromes de inmunodeficiencia, Otros calificadores::Otros calificadores::/diagnóstico, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas, ATENCIÓN DE SALUD::calidad, acceso y evaluación de la atención sanitaria::calidad de la atención sanitaria::factores epidemiológicos::comorbilidad

وصف الملف: application/pdf

العلاقة: Frontiers in Immunology;10; https://www.frontiersin.org/articles/10.3389/fimmu.2019.00586/fullTest; Sánchez-Ramón S, Bermúdez A, González-Granado LI, Rodríguez-Gallego C, Sastre A, Soler-Palacín P, et al. Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management. Front Immunol. 2019;10:586.; https://hdl.handle.net/11351/4143Test; WOS:000462540900001

الإتاحة: https://doi.org/10.3389/fimmu.2019.00586Test
https://hdl.handle.net/11351/4143Test